Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry

J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e887-e891. doi: 10.1111/jdv.19979. Epub 2024 Mar 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Azetidines* / therapeutic use
  • Dermatitis, Atopic* / drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Purines* / therapeutic use
  • Pyrazoles* / therapeutic use
  • Registries*
  • Severity of Illness Index
  • Sulfonamides* / therapeutic use

Substances

  • baricitinib
  • Pyrazoles
  • Sulfonamides
  • Azetidines
  • Purines